EcoDrugPlus

Uncharacterized Loc116065255

Ensembl ID : ENSSLUG00000008203
Gene Symbol: LOC116065255
2 Cross references
196 Possible Orthologues:

Utrophin

Ensembl ID : ENSSLUG00000011798
Gene Symbol: UTRN
1 Cross references
270 Possible Orthologues:

V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog

Ensembl ID : ENSSLUG00000022895
Gene Symbol: KRAS
1 Cross references
207 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSSLUG00000018869
Gene Symbol: VEGFA
3 Cross references
201 Possible Orthologues:

Vascular Endothelial Growth Factor A-A-Like

Ensembl ID : ENSSLUG00000020512
Gene Symbol: LOC116059810
3 Cross references
181 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSSLUG00000022658
Gene Symbol: VDR
3 Cross references
388 Possible Orthologues:

Vitamin D3 Receptor B

Ensembl ID : ENSSLUG00000000609
Gene Symbol: LOC116067703
3 Cross references
392 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like Protein 1

Ensembl ID : ENSSLUG00000003769
Gene Symbol: LOC116061570
3 Cross references
190 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-3 Subunit-Like

Ensembl ID : ENSSLUG00000016122
Gene Symbol: LOC116057229
2 Cross references
190 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSSLUG00000019912
Gene Symbol: LOC116059662
3 Cross references
189 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-5 Subunit-Like

Ensembl ID : ENSSLUG00000010222
Gene Symbol: LOC116043014
3 Cross references
184 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-6 Subunit-Like

Ensembl ID : ENSSLUG00000006394
Gene Symbol: LOC116046391
3 Cross references
182 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).